Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55.8Revenue (TTM) $M5.2Net Margin (%)3,707Altman Z-Score3.1
Enterprise Value $M-165.0EPS (TTM) $2.9Operating Margin %-215.4Piotroski F-Score5
P/E(ttm)0.3Beneish M-Score-10.7Pre-tax Margin (%)3,920Higher ROA y-yY
Price/Book2.710-y EBITDA Growth Rate %-36.6Quick Ratio1.1Cash flow > EarningsY
Price/Sales9.65-y EBITDA Growth Rate %4.8Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow0.3y-y EBITDA Growth Rate %--ROA % (ttm)224Higher Current Ratio y-yN
Dividend Yield %--PEG0.1ROE % (ttm)456Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M68.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PIP

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PIP is held by these investors:



PIP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PRESCOTT GROUP CAPITAL MANAGEM10% Owner 2016-12-09Sell1,354,632$3.26-76.38view
RICHMAN ERIC IDirector 2016-04-13Sell329,354$2.2-65view
RICHMAN ERIC IDirector 2016-04-08Sell11,767$2.2-65view
St Peter StevenDirector 2015-03-19Buy25,000$1.65-53.33view
CHANG LINDA LSVP, CFO & Secretary 2015-01-07Sell29,600$2.1-63.33view
PRESCOTT GROUP CAPITAL MANAGEM10% Owner 2014-09-22Buy15,000$1.55-50.32view
Runge Jeffrey W.Director 2011-12-12Buy20,000$1.3-40.77view
FUERST THOMAS RICHARDSVP, Chief Scientific Officer 2011-11-22Buy5,000$1.27-39.37view
CHANG LINDA LSVP & CFO 2011-11-16Buy10,000$1.38-44.2view
SAYARE MITCHELDirector 2011-08-18Buy5,000$2.17-64.52view

Press Releases about PIP :

Quarterly/Annual Reports about PIP:

News about PIP:

Articles On GuruFocus.com
Altimmune Receives $7.3 Million Contract Modification from BARDA to Fund Manufacturing of its First- Mar 28 2017 
Weekly CFO Buys Highlight: BWEN, ENZ, PIP, HAFC, AACC Nov 21 2011 
PharmAthene Inc (PIP) CEO Eric I Richman buys 10,000 Shares Jun 21 2010 
Guru Activities for Today’s Price % Losers: PharmAthene Inc. , Authentidate Holding Corp., Kroger Dec 08 2009 

More From Other Websites
ETFs with exposure to PharmAthene, Inc. : April 19, 2017 Apr 19 2017
Altimmune Receives $7.3 Million Contract Modification from BARDA to Fund Manufacturing of its... Mar 28 2017
PharmAthene, Inc. :PIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Mar 21 2017
PharmAthene Reports Year-End 2016 Financial and Operational Results Mar 14 2017
PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding... Mar 13 2017
Five Penny Stocks to Buy Now Mar 07 2017
Pepsico CFO: Great business in Mexico Feb 15 2017
Pepsico CFO: We have terrific momentum Feb 15 2017
Biotech Premarket Movers: PharmAthene, Earth Science Tech, Pulmatrix Feb 07 2017
Rite Aid, Supervalu Slump into Monday’s 52-Week Low Club Feb 06 2017
Altimmune to Present at the BIO CEO & Investor Conference Feb 06 2017
[$$] Gormley's Take: As IPO Market Tightens, Biotechs Find Another Route to Public Listing Feb 01 2017
PharmAthene and Altimmune to Merge in All-Stock Deal Jan 23 2017
ETFs with exposure to PharmAthene, Inc. : January 20, 2017 Jan 20 2017
Blog Coverage PharmAthene and Altimmune Announced a Merger; Set to Establish Immunotherapeutic... Jan 20 2017
Two of region's anthrax-fighting companies announce merger Jan 20 2017
PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious... Jan 19 2017
ETFs with exposure to PharmAthene, Inc. : December 5, 2016 Dec 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)